openPR Logo
Press release

Cancer Anorexia Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Helsinn Healthcare, Artelo Biosciences, NGM Biopharma

03-07-2025 02:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Cancer Anorexia Market to Show Remarkable Growth Trends from

The Key Cancer Anorexia Companies in the market include - Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others.
DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Cancer Anorexia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Anorexia Market Forecast [https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Cancer Anorexia Market Report:

*
The Cancer Anorexia market size was valued approximately ~USD 310 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
In November 2024, Endevica Bio's investigational peptide, designed to counteract cachexia-related weight loss, demonstrated significant benefits in preclinical rodent models of cancer chemotherapy. According to a study published in the Journal of Clinical Investigation, the peptide, TCMCB07 (B07), improved appetite while maintaining lean and fat mass. These findings highlight the promising potential of TCMCB07 to address chemotherapy-induced anorexia and weight loss, offering hope to millions of patients globally.

*
In 2023, the US reported around 277,200 cases of cancer anorexia, with an expected increase throughout the forecast period.

*
In the EU4 and the UK, Germany had the highest number of cancer anorexia incident cases, whereas Spain had the fewest.

*
Lung cancer represents the highest number of anorexia incident cases among all cancer types, with approximately 150,300 cases in the US.

*
The anticipated launch of promising therapies ART27.13 (Artelo Biosciences) and NGM120 (NGM Biopharmaceuticals) is expected to drive market growth in the coming years, supported by a rise in the incident population of cancer anorexia.

*
Key Cancer Anorexia Companies: Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others

*
Key Cancer Anorexia Therapies: ADLUMIZ/EDOLMIZU, Adlumiz, ART27.13, NGM120, and others

*
The Cancer Anorexia epidemiology based on gender analyzed that Cancer Anorexia occurs in both men and women

*
The Cancer Anorexia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cancer Anorexia pipeline products will significantly revolutionize the Cancer Anorexia market dynamics.

Cancer Anorexia Overview

The cancer anorexia-cachexia syndrome (CACS), which includes anorexia, is a common sign of cancer.Reduced intake is caused by a lack of appetite or a loss of desire to eat, however this alone cannot explain the complex changes that characterize the CACS.

Get a Free sample for the Cancer Anorexia Market Report

https://www.delveinsight.com/report-store/cancer-anorexia-market [https://www.delveinsight.com/report-store/cancer-anorexia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Cancer Anorexia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Cancer Anorexia Epidemiology Segmentation:

The Cancer Anorexia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

*
Total Prevalence of Cancer Anorexia

*
Prevalent Cases of Cancer Anorexia by severity

*
Gender-specific Prevalence of Cancer Anorexia

*
Diagnosed Cases of Episodic and Chronic Cancer Anorexia

Download the report to understand which factors are driving Cancer Anorexia epidemiology trends @ Cancer Anorexia Epidemiology Forecast [https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Cancer Anorexia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cancer Anorexia market or expected to get launched during the study period. The analysis covers Cancer Anorexia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Cancer Anorexia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Cancer Anorexia Therapies and Key Companies

*
ADLUMIZ/EDOLMIZU: Helsinn Healthcare

*
Adlumiz: Helsinn Healthcare

*
ART27.13: Artelo Biosciences

*
NGM120: NGM Biopharmaceuticals

Discover more about therapies set to grab major Cancer Anorexia market share @ Cancer Anorexia Treatment Market [https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Cancer Anorexia Market Drivers

*
An increasing population of cancer patients with anorexia in the 7MM

*
Scope of upcoming therapies

*
Opportunity for novel treatments

*
Presence of effective disease scoring system

Cancer Anorexia Market Barriers

*
Disease burden and impact on the quality of life

*
Lack of knowledge about the condition

*
The high mortality rate in cancer patients due to anorexia

Scope of the Cancer Anorexia Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Cancer Anorexia Companies: Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others

*
Key Cancer Anorexia Therapies: ADLUMIZ/EDOLMIZU, Adlumiz, ART27.13, NGM120, and others

*
Cancer Anorexia Therapeutic Assessment: Cancer Anorexia current marketed and Cancer Anorexia emerging therapies

*
Cancer Anorexia Market Dynamics: Cancer Anorexia market drivers and Cancer Anorexia market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Cancer Anorexia Unmet Needs, KOL's views, Analyst's views, Cancer Anorexia Market Access and Reimbursement

To know more about Cancer Anorexia companies working in the treatment market, visit @ Cancer Anorexia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Cancer Anorexia Market Report Introduction

2. Executive Summary for Cancer Anorexia

3. SWOT analysis of Cancer Anorexia

4. Cancer Anorexia Patient Share (%) Overview at a Glance

5. Cancer Anorexia Market Overview at a Glance

6. Cancer Anorexia Disease Background and Overview

7. Cancer Anorexia Epidemiology and Patient Population

8. Country-Specific Patient Population of Cancer Anorexia

9. Cancer Anorexia Current Treatment and Medical Practices

10. Cancer Anorexia Unmet Needs

11. Cancer Anorexia Emerging Therapies

12. Cancer Anorexia Market Outlook

13. Country-Wise Cancer Anorexia Market Analysis (2020-2034)

14. Cancer Anorexia Market Access and Reimbursement of Therapies

15. Cancer Anorexia Market Drivers

16. Cancer Anorexia Market Barriers

17. Cancer Anorexia Appendix

18. Cancer Anorexia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cancer-anorexia-market-to-show-remarkable-growth-trends-from-2024-to-2034-delveinsight-reports-helsinn-healthcare-artelo-biosciences-ngm-biopharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Anorexia Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Helsinn Healthcare, Artelo Biosciences, NGM Biopharma here

News-ID: 3904719 • Views:

More Releases from ABNewswire

The Debut Album of Soldier'z of the Most High (S.O.T.M.H): The City in the Sky Now Available on All Major Platforms - SalvationMusic.com
The Debut Album of Soldier'z of the Most High (S.O.T.M.H): The City in the Sky N …
From sourthern roots and legendary encounters to a new sound called Salvation Music, Chattanooga's own Freddy Mac delivers his long-awaited debut album. Chattanooga, TN - The wait is over. Freddy Mac 2025 and his band Soldier'z of the Most High (S.O.T.M.H) proudly unveil their long-anticipated debut album, The City in the Sky. This groundbreaking project introduces Salvation Music [http://www.salvationmusic.com], a bold fusion of funk, metal, soul, and classical influences, brought to
Author's Tranquility Press Announces the Heartwarming Release of Lil' Hal's Giant Christmas Box
Author's Tranquility Press Announces the Heartwarming Release of Lil' Hal's Gian …
A Christmas Tale of Wonder, Patience, and Family Love That Shines Beyond the Wrapping Paper Few things capture the spirit of Christmas like the thrill of a child discovering a gift under the tree. In Lil' Hal's Giant Christmas Box [https://www.amazon.com/Lil-Hals-Giant-Christmas-Box/dp/195754662X/ref=monarch_sidesheet_title] by Christy B., readers are invited into a magical holiday morning filled with suspense, laughter, and an unforgettable lesson: sometimes the greatest gifts require patience, faith, and love. This beautifully illustrated
"The Expedia of VoIP": Business Phone System Disrupts Carrier Model with Transpa …
Business owners can now shop multiple providers at once-choosing the right system without sales pressure or hidden fees. Sheridan, Wyoming - Business Phone System, a vendor-neutral platform for business communications, today announced its official launch, offering business owners a smarter way to evaluate and select telecom services. Unlike traditional carriers that push their own packages, Business Phone System enables organizations to compare multiple providers side-by-side, ensuring the right solution is sized
Skerrit Bwoy Launches Explosive New Single
Skerrit Bwoy Launches Explosive New Single "Satan Dead" - A Bold Christian EDM A …
Album Release: August 29, 2025 New York, NY - Antiguan-born, Bronx-raised producer and DJ Skerrit Bwoy, widely recognized as "Mr. Jesus Party", is set to shake the Christian music scene with the release of his latest single, "Satan Dead." Available today on all major streaming platforms, the track delivers a powerful fusion of festival-ready EDM drops, Caribbean dancehall vibes, and unapologetically Gospel-driven lyrics. More than just a song, "Satan Dead" is a

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For